Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that target central nervous system disorders. Its structure allows for the introduction of the aminomethylpiperidine moiety, which is commonly found in bioactive molecules due to its favorable pharmacokinetic properties and ability to interact with various receptors. Commonly employed in medicinal chemistry for constructing drug candidates involving receptor agonists or antagonists, especially in neuropharmacology. Also utilized in the preparation of selective enzyme inhibitors and receptor modulators in research settings.